Karen S Anderson Selected Research

Karen S Anderson Research Topics

Disease

62	Neoplasms (Cancer) 01/2024 - 06/2003
26	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2008
16	Infections 04/2024 - 05/2003
10	Acquired Immunodeficiency Syndrome (AIDS) 10/2020 - 04/2002
7	COVID-19 04/2024 - 08/2020
7	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 03/2009
6	Oropharyngeal Neoplasms 02/2018 - 07/2015
6	HIV Infections (HIV Infection) 01/2017 - 02/2004
4	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2018
4	Triple Negative Breast Neoplasms 11/2017 - 02/2011
4	Malaria 09/2014 - 02/2008
3	Disease Progression 03/2024 - 06/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 05/2010
3	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2007
3	Carcinogenesis 12/2017 - 02/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2013 - 05/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2020 - 01/2016
2	Melanoma (Melanoma, Malignant) 05/2020 - 02/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019 - 10/2018
2	Carcinoma (Carcinomatosis) 06/2015 - 02/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 06/2012
2	Human Influenza (Influenza) 06/2011 - 06/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023
1	Rare Diseases (Rare Disease) 12/2022
1	Cholangiocarcinoma 10/2022
1	Hot Flashes 05/2020
1	Residual Neoplasm 01/2019

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2005
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
18	AntigensIBA 01/2024 - 06/2003
13	AutoantibodiesIBA 01/2024 - 04/2008
13	AntibodiesIBA 01/2021 - 07/2005
10	EnzymesIBA 10/2018 - 11/2003
9	VaccinesIBA 11/2023 - 07/2005
9	Neoplasm Antigens (Tumor Antigens)IBA 01/2017 - 07/2005
8	Peptides (Polypeptides)IBA 01/2022 - 02/2004
8	EpitopesIBA 03/2019 - 09/2010
8	NucleosidesIBA 01/2019 - 06/2009
7	Antiviral Agents (Antivirals)IBA 04/2024 - 07/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2005
7	Immunoglobulin G (IgG)IBA 01/2021 - 01/2011
7	Reverse Transcriptase InhibitorsIBA 01/2019 - 06/2009
6	Estrogen ReceptorsIBA 05/2020 - 02/2011
5	Phosphotransferases (Kinase)IBA 05/2015 - 03/2007
5	thymidylate synthase-dihydrofolate reductaseIBA 02/2014 - 02/2008
4	Complement System Proteins (Complement)IBA 01/2024 - 01/2020
4	NucleotidesIBA 12/2014 - 02/2008
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
3	OligonucleotidesIBA 01/2022 - 09/2015
3	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 08/2020
3	DNA Polymerase gammaIBA 01/2019 - 05/2010
3	N 30IBA 01/2018 - 03/2010
3	AutoantigensIBA 01/2017 - 02/2004
3	Gefitinib (Iressa)FDA Link 04/2015 - 03/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 09/2014 - 01/2009
3	Thymidylate SynthaseIBA 09/2014 - 10/2013
3	HLA-A*02:01 antigenIBA 06/2011 - 06/2003
2	Capecitabine (Xeloda)FDA Link 01/2024 - 09/2023
2	Gemcitabine FDA Link 01/2024 - 09/2023
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2022 - 05/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2022 - 08/2005
2	CytidineIBA 01/2022 - 10/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 12/2017
2	Cancer VaccinesIBA 12/2018 - 05/2009
2	CytosineIBA 10/2018 - 07/2002
2	InterferonsIBA 10/2018 - 03/2009
2	Oncogene Proteins (Oncogene Protein)IBA 12/2017 - 09/2010
2	Human immunodeficiency virus 1 reverse transcriptaseIBA 01/2017 - 08/2010
2	Mitochondrial DNA (mtDNA)IBA 01/2016 - 06/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2015 - 03/2007
2	Tenofovir (Viread)FDA Link 12/2014 - 08/2012
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 09/2014 - 10/2013
2	Immunodominant EpitopesIBA 08/2014 - 06/2003
2	LigandsIBA 08/2014 - 02/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2014 - 12/2007
2	Antiparasitic Agents (Antiparasitics)IBA 10/2013 - 09/2013
2	Viral AntigensIBA 06/2011 - 06/2003
2	IntegrinsIBA 04/2011 - 02/2011
1	nirmatrelvir and ritonavir drug combinationIBA 04/2024
1	OsteopontinIBA 01/2024
1	TNF Receptor-Associated Factor 3IBA 01/2023
1	Estrogen Receptor alphaIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 12/2022
1	Dual Specificity Phosphatase 1IBA 12/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2022
1	Drug CombinationsIBA 01/2022
1	perampanelIBA 03/2021
1	Azacitidine (5 Azacytidine)FDA Link 12/2020
1	MethyltransferasesIBA 05/2020
1	Acetates (Acetic Acid Esters)FDA Link 05/2020
1	Estrogens (Estrogen)FDA Link 05/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2019
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2019

Therapy/Procedure

25	Therapeutics 01/2024 - 11/2003
8	Immunotherapy 03/2019 - 06/2003
4	Drug Therapy (Chemotherapy) 09/2022 - 08/2005
3	Highly Active Antiretroviral Therapy (HAART) 10/2020 - 07/2008
2	Neoadjuvant Therapy 01/2019 - 12/2017
1	Radiotherapy 09/2022